Prostate Cancer - Results from #26100

Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate - Abstract April 2, 2012

Prostate Cancer Grading & Staging Systems April 1, 2012

Prostate Cancer Screening April 1, 2012

EAU 2012 - The key role of time in predicting post-radical prostatectomy urinary continence recovery rate: Conditional survival analysis - Session Highlights March 30, 2012

EAU 2012 - Dynamics of the pelvic floor in continent and stress urinary incontinent men after radical prostatectomy: A functional MRI study - Session Highlights March 30, 2012

EAU 2012 - Clinical prognosis and predictive factors of the further recovery of urinary continence in patients who do not achieve continence within 1 year after radical prostatectomy: 42 months follow-up - Session Highlights March 30, 2012

EAU 2012 - Introducing a nurse-led trans-perineal saturation prostate biopsy (TPSBx) service - Session Highlights March 30, 2012

Circulating tumor cells as a marker of response: Implications for determining treatment efficacy and evaluating new agents - Abstract March 30, 2012

Current status of immunological approaches for the treatment of prostate cancer - Abstract March 30, 2012

Tracking target position variability using intraprostatic fiducial markers and electronic portal imaging in prostate cancer radiotherapy - Abstract March 30, 2012

Predictive models for biochemical recurrence of prostate cancer after local treatment. Nomograms - Abstract March 30, 2012

Biochemical recurrence in patients with prostate cancer after radical treatment. Comparative study of prostatectomy vs. radiotherapy - Abstract March 30, 2012

The evolving paradigm of second-line hormonal therapy options for castration-resistant prostate cancer - Abstract March 30, 2012

The concept of erectile function preservation (penile rehabilitation) in the patient after brachytherapy for prostate cancer - Abstract March 30, 2012

Evolution of treatment options for patients with CRPC and bone metastases: Bone-targeted agents that go beyond palliation of symptoms to improve overall survival - Abstract March 30, 2012

Trends in pathologic outcomes after introduction of active surveillance in the UK: Implication for focal therapy - Abstract March 30, 2012

Novel strategies in the treatment of castration-resistant prostate cancer (Review) - Abstract March 29, 2012

Efficacy of estramustine phosphate according to risk classification of castration-resistant prostate cancer - Abstract March 29, 2012

Diet, obesity, and prostate health: Are we missing the link? - Abstract March 29, 2012

Three-tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: Detection of clinically significant prostate cancers - Abstract March 29, 2012

Page 1306 of 1436